FDA's Overreach on Compounded Peptides
US$ 27.56
suppliers of bpc 157 BPC-157 + TB-500 — 10 mg BPC-157/TB-500 - Pure Health Peptides
Description
Larazotide is currently being studied for illnesses of intestinal permeability and is the subject of a late-phase clinical trial for patients with celiac disease, whose intestinal barrier is compromised
Compounded medications are only indicated for patients when a prescribing practitioner determines that the compounded preparation produces a significant difference for their patient compared to the FDA-approved product
They track adverse reactions of all kinds
Room-temperature storage, ships from Canada
